Nix D - Search Results

1

Coccidioidomycosis as a common cause of community-acquired pneumonia.

Valdivia L, Nix D, Wright M, Lindberg E, Fagan T, Lieberman D, Stoffer T, Ampel NM, Galgiani JN. Valdivia L, et al. Among authors: nix d. Emerg Infect Dis. 2006 Jun;12(6):958-62. doi: 10.3201/eid1206.060028. Emerg Infect Dis. 2006. PMID: 16707052 Free PMC article.

2

Pharmacokinetics of nikkomycin Z after single rising oral doses.

Nix DE, Swezey RR, Hector R, Galgiani JN. Nix DE, et al. Antimicrob Agents Chemother. 2009 Jun;53(6):2517-21. doi: 10.1128/AAC.01609-08. Epub 2009 Apr 6. Antimicrob Agents Chemother. 2009. PMID: 19349517 Free PMC article. Clinical Trial.

3

Efficacy of Nikkomycin Z for respiratory coccidioidomycosis in naturally infected dogs.

Shubitz LF, Roy ME, Nix DE, Galgiani JN. Shubitz LF, et al. Med Mycol. 2013 Oct;51(7):747-54. doi: 10.3109/13693786.2013.770610. Epub 2013 Mar 14. Med Mycol. 2013. PMID: 23488972

4

Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis.

Nguyen C, Barker BM, Hoover S, Nix DE, Ampel NM, Frelinger JA, Orbach MJ, Galgiani JN. Nguyen C, et al. Clin Microbiol Rev. 2013 Jul;26(3):505-25. doi: 10.1128/CMR.00005-13. Clin Microbiol Rev. 2013. PMID: 23824371 Free PMC article. Review.

5

Modeling nikkomycin Z dosing and pharmacology in murine pulmonary coccidioidomycosis preparatory to phase 2 clinical trials.

Shubitz LF, Trinh HT, Perrill RH, Thompson CM, Hanan NJ, Galgiani JN, Nix DE. Shubitz LF, et al. J Infect Dis. 2014 Jun 15;209(12):1949-54. doi: 10.1093/infdis/jiu029. Epub 2014 Jan 12. J Infect Dis. 2014. PMID: 24421256 Free PMC article.

6

Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis.

Eljaaly K, Alshehri S, Aljabri A, Abraham I, Al Mohajer M, Kalil AC, Nix DE. Eljaaly K, et al. BMC Infect Dis. 2017 Jun 2;17(1):385. doi: 10.1186/s12879-017-2495-5. BMC Infect Dis. 2017. PMID: 28576117 Free PMC article.

7

Current Concepts and Future Directions in the Pharmacology and Treatment of Coccidioidomycosis.

Thompson GR 3rd, Lewis JS 2nd, Nix DE, Patterson TF. Thompson GR 3rd, et al. Med Mycol. 2019 Feb 1;57(Supplement_1):S76-S84. doi: 10.1093/mmy/myy029. Med Mycol. 2019. PMID: 30690601 Review.

8

Clinical and Economic Burden of Valley Fever in Arizona: An Incidence-Based Cost-of-Illness Analysis.

Grizzle AJ, Wilson L, Nix DE, Galgiani JN. Grizzle AJ, et al. Open Forum Infect Dis. 2020 Dec 28;8(2):ofaa623. doi: 10.1093/ofid/ofaa623. eCollection 2021 Feb. Open Forum Infect Dis. 2020. PMID: 33575419 Free PMC article.

9

Remarks on the Universal Lifelong Coccidioidomycosis Prophylaxis in Lung Transplant Recipients.

Al-Obaidi MM, Nematollahi S, Nix DE, Zangeneh TT. Al-Obaidi MM, et al. Clin Infect Dis. 2022 May 30;74(10):1885-1886. doi: 10.1093/cid/ciab878. Clin Infect Dis. 2022. PMID: 34738618 No abstract available.

10

Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians.

Nix DE, Majumdar AK, DiNubile MJ. Nix DE, et al. J Antimicrob Chemother. 2004 Jun;53 Suppl 2:ii23-8. doi: 10.1093/jac/dkh205. J Antimicrob Chemother. 2004. PMID: 15150180 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters